INTRODUCTION
============

Laparoendoscopic single-site surgery (LESS) has been proposed as an evolutionary step beyond standard laparoscopy and has been increasingly adopted by urologists worldwide since its introduction \[[@B1],[@B2]\]. Conceptually, it is driven by the hypothesis that minimization of the skin incision to gain access to the abdominal or pelvic cavities may benefit patients in terms of port-related complications, recovery time, pain, and cosmesis \[[@B3],[@B4]\].

Over the past few years, many standard laparoscopic operations in urology have been successfully performed with the use of LESS. However, the actual role of LESS in the field of minimally invasive urologic surgery remains to be determined \[[@B5],[@B6]\].

The purpose of this review was to update the current status of LESS in urologic surgery.

BASIC PRINCIPLES AND TERMINOLOGY
================================

The first LESS Consortium for Assessment and Research was organized in Cleveland, Ohio, in July 2008 \[[@B3]\]. Subsequently, other organizations included their recommendations, making the term \"LESS\" broader by encompassing the following concepts: 1) a single entry port; 2) applicability to multiple locations (abdomen, pelvis, thorax); 3) laparoscopic, endoscopic, or robotic surgery; 4) umbilical or extraumbilical access; 5) intra- and transluminal (percutaneous single-port access) approaches \[[@B2],[@B3],[@B6]\].

LESS access can be obtained either by making a single skin and fascial incision in which a single multi-channel access platform is placed (single-port) or by placing several low-profile ports through separate fascial incisions (single-site). The access point can be umbilical or extraumbilical.

LESS: CURRENTLY AVAILABLE TOOLS FOR UROLOGIC APPLICATIONS
=========================================================

Despite evolving from the concepts and techniques of standard laparoscopy, LESS defies some basic laparoscopic principles, including instrument and external port spacing to decrease clashing. New laparoscopic access devices, optics, and instrumentation specifically designed for successfully facilitating LESS have been developed in the past few years \[[@B5],[@B7]-[@B9]\] ([Table 1](#T1){ref-type="table"}).

ACCESS DEVICES
==============

Multichannel ports can be used during LESS as one approach to access. These devices allow for the insertion of instruments and a camera and involve a single fascial incision.

The TriPort port (Olympus Co., Tokyo, Japan), previously known as R-port, is the first multi-instrument port designed specifically for LESS \[[@B10]\]. The SILS port (Covidien, Mansfield, MA, USA) is a foam port that expands after insertion to prevent air leakage. The GelPOINT port (Applied Medical Resources Co., Rancho Santa Margarita, CA, USA) is similar to the already available GelPort port but with a smaller diameter. The AirSeal port (SurgiQuest, Orange, CT, USA) maintains pneumoperitoneum by creating an air vortex \[[@B11]\].

Alternatively, LESS access can be obtained with the use of several low-profile, small-diameter head trocars (such as AnchorPort trocars \[SurgiQuest\], Pediport trocars \[Covidien\], and Hunt trocars \[Apple Medical Resources Co.\]) with separate fascial stab incisions (single site). These devices can be clustered within a single incision or through three separate stab incisions clustered within the umbilical ring.

Initial clinical experience with LESS nephrectomy using a homemade single-port device has also been reported \[[@B12],[@B13]\]. In those reports, an Alexis wound retractor was inserted at the umbilicus, and a surgical glove was installed over the outer ring of the wound retractor. About 3 to 4 fingers of the glove were cut, and one 10-mm and two or three 5-mm trocars were placed. The fingers of the glove were secured to the end of the trocars with a rubber band and fixed to the outer ring of the wound retractor. The device provided adequate range of motion and enough flexibility in port placement for LESS.

INSTRUMENTS
===========

When instruments are inserted in parallel through the same site, clashing and decreased maneuverability represent major limitations. Articulating instruments have been developed to allow the surgeon\'s hands to be positioned apart from each other while maintaining the tips of the instruments still focused on the same point inside the abdomen. A combination of conventional and flexible (articulating) instruments provides improved intraoperative ergonomics \[[@B7]-[@B9]\]. Traditional rigid, straight instruments have also been used for LESS. Branco et al. \[[@B14]\] evaluated LESS urologic surgery with the use of conventional laparoscopic instruments and ports, claiming that articulating instruments might not be strictly necessary.

Pre-bent instruments have been introduced with the aim of minimizing instrument clashing outside the port, providing triangulation in the operative field and better force application at instrument tip during dissection \[[@B15]\]. These instruments are also cost-effective, because they are reusable compared with the single-use disposable flexible instruments. Stolzenburg et al. \[[@B16]\] recently performed a comparative evaluation in a dry and animal laboratory of conventional, flexible, and pre-bent instruments in an attempt to elucidate instrument effectiveness and maneuverability. Pre-bent instruments proved to be less time-consuming and provided better maneuverability.

With the rise of LESS and natural orifice translumenal endoscopic surgery (NOTES), needlescopic instruments have also been re-discovered, because they can be introduced through a small puncture that requires no formal closure, thus pursuing the philosophy of scarless surgery.

OPTICS
======

A key problem with conventional laparoscopes is that they have a large extracorporeal profile, with a light cable exiting at 90°. This configuration leads to clashing of instruments and the camera during LESS. Thus, the ideal telescope for LESS should remove the light cord and camera head from the operative field. Low-profile camera systems have been introduced for this purpose \[[@B7]-[@B9]\].

Articulating laparoscopes, such as the EndoEYE (Olympus, Tokyo, Japan) or the IDEAL EYES (Stryker, Kalamazoo, MI, USA), represent additional tools for the single-port armamentarium. One issue with articulating scopes is the plastic casing that covers the flexible part of the tip, which tends to degrade over time. The camera chip in the 10-mm EndoCAMeleon (Karl Storz, Tuttlingen, Germany) scope rotates within the tip, thus eliminating the need for the plastic casing while still giving surgeons the multidirectional view they need to operate. Moreover, 5-mm, 308, extra-long telescopes have been developed and marketed for LESS. The extra length removes the camera head and light cord from the operative field.

PATIENT SELECTION
=================

All eligible laparoscopic surgery patients may be considered for LESS depending on the surgeons\' LESS experience. When starting LESS, patient selection criteria are expected to be stringent. Disease features (i.e., locally advanced disease requires more extensive dissection and abnormal anatomy requires extensive suturing) and characteristics of the patients (i.e., body habitus, body mass index, comorbidity score, previous surgery or radiation, and personal preferences for better cosmetic outcome) should be considered. A low threshold for conversion to standard laparoscopy or even open surgery must be adopted.

CLINICAL STATUS
===============

Currently, the feasibility and safety of major urological extirpative, ablative, and reconstructive procedures has been reported worldwide \[[@B3],[@B5],[@B7],[@B17]-[@B38]\] ([Table 2](#T2){ref-type="table"}). However, longer clinical follow-up remains to be determined for each LESS procedure.

ROBOTIC LESS
============

Robotic manipulation of instrumentation to address the current constraints and limitations of LESS has also been tested. The first successful series of single-port robotic procedures in humans, including radical prostatectomy, dismembered pyeloplasty, and radical nephrectomy, were reported by Kaouk et al. \[[@B39]\]. A robotic 12-mm scope and a 5-mm grasper were introduced through a multichannel single port (R-Port), whereas an additional 5- or 8-mm robotic port was introduced through the same umbilical incision (2 cm) alongside the multichannel port to facilitate entry of robotic instruments. Predictably, the robotic instrument articulation allowed the surgeon to perform a less challenging operative maneuvering.

Further expanding the application of robotics to LESS, Kaouk and Goel \[[@B40]\] reported an initial experience with single-port robotic partial nephrectomy in two patients. Moreover, Han et al. \[[@B41]\] have recently reported their cumulative experience with robot-assisted LESS partial nephrectomy to treat 14 cases of renal cell carcinoma (mean tumor size, 3.2 cm). Stein et al. \[[@B42]\] used a GelPort (Applied Medical Resources Co.) as an access platform for robotic LESS. Four LESS procedures were successfully performed, including two pyeloplasties, one radical nephrectomy, and one partial nephrectomy. In addition, adequate trocar spacing and flexibility of placement allowed the surgical assistant to actively assist the surgeon during the LESS. The surgical technique and reported early outcomes of robotic LESS radical prostatectomy have also been more recently described \[[@B28]\].

LESS VS CONVENTIONAL LAPAROSCOPY
================================

Comparative series between conventional laparoscopy and LESS have recently become available ([Table 3](#T3){ref-type="table"}).

Raman et al. \[[@B43]\] were the first to report a case-control study comparing LESS with conventional laparoscopy. They compared 11 LESS procedures with 22 laparoscopic nephrectomies. According to the authors, the superiority of LESS over standard laparoscopic nephrectomy was \"limited\" to a mere subjective cosmetic advantage, even if this advantage was not specifically measured or quantified.

Considering that in this study, half of the LESS patients had a nephrectomy for malignancy, necessitating extension of the initial umbilical incision for specimen extraction, the investigators speculated that this may have blunted the potential benefit of LESS. Therefore, they addressed a reconstructive procedure, such as pyeloplasty. Fourteen patients undergoing LESS pyeloplasty were matched 2:1 with regard to age and side of surgery to a previous cohort of 28 patients who underwent laparoscopic pyeloplasty \[[@B44]\]. Suturing was aided through a 5-mm instrument placed in the eventual drain site. Interestingly, median operative times and median estimated blood loss (EBL) were significantly lower in patients undergoing LESS. The authors claimed that the 50-ml difference in blood loss was not likely to be clinically significant and was probably related to the inevitable inaccuracies in intraoperative measurement. Regarding the operating room time, they partially attributed the difference to the fact that 75% of control patients underwent cystoscopy with retrograde stent placement, which requires repositioning of the patient and additional equipment compared to the antegrade stent placement performed in all LESS cases. In addition, more patients in the laparoscopy cohort had previous endoscopic management of their ureteropelvic junction, which may have made dissection more difficult.

Jeong et al. \[[@B45]\] recently described the first study comparing LESS with laparoscopy in the treatment of benign adrenal adenoma. Nine patients undergoing LESS adrenalectomy were compared with 17 matched patients undergoing conventional laparoscopic adrenalectomy. Postoperative pain, as measured by the mean number of days of intravenous patient-controlled anesthesia use, was significantly lower in the LESS group. LESS adrenalectomy was comparable to the conventional laparoscopic approach in terms of perioperative parameters. The authors claimed a higher cosmetic outcome, even if this outcome was not specifically measured.

Raybourn et al. \[[@B46]\] matched a total of 11 patients undergoing LESS simple nephrectomy with a group of 10 patients who previously underwent simple laparoscopic nephrectomy. All LESS procedures were completed with no intraoperative complications. Postoperative complications included fever and port site bruising in two patients. No difference was detected in the analgesia requirement between matched groups. The authors claimed an obvious cosmetic advantage, even if it was not specifically quantified.

White et al. \[[@B47]\] performed a retrospective cohort study to determine the efficacy and safety of LESS abdominal sacral colpopexy for the treatment of female pelvic organ prolapse. Despite a limited postoperative follow-up, the procedure appeared to be comparable to the laparoscopic and robotic approaches in terms of efficacy but with superior cosmesis.

The same group from the Cleveland Clinic retrospectively compared single-port retroperitoneal cryoablation with standard retroperitoneoscopy \[[@B48]\]. Subjective evaluation by the patients of postoperative pain was significantly in favor of the LESS approach, but the amount of analgesics used in each group was not reported, partially mitigating the clinical significance of this finding.

Two retrospective matched-pair comparisons of LESS to standard laparoscopic live-donor nephrectomy were recently reported \[[@B49],[@B50]\] ([Table 4](#T4){ref-type="table"}). Canes et al. \[[@B49]\] performed the LESS procedure through an intra-umbilical multichannel port, using a 5-mm rigid laparoscope with integrated camera head, with standard and curved/articulating instruments. The kidney was extracted through a slightly extended umbilical incision. Mean warm ischemia time was significantly longer in the LESS group, even if allograft function was comparable between groups at 3 months. Patients undergoing LESS donor nephrectomy had similar in-hospital analgesic requirements and mean visual analogue scale (VAS) scores at discharge, but their convalescence, as assessed by considering days on oral pain medication, days off work, and days to full physical recovery, was faster.

Andonian et al. \[[@B50]\] compared their LESS Pfannenstiel donor nephrectomy with a series of standard laparoscopic donor nephrectomy procedures. In the LESS group, there were no conversions to laparoscopy or open surgery. The laparoscopic group included more right-sided patients and more venous anomalies. No significant difference was found between the groups in terms of operative time, warm ischemia time, EBL, length of hospital stay, or total morphine equivalents. A patient in the laparoscopic group developed a wound infection. There were no perioperative complications in the LESS group. Postoperative VAS scores were lower in the LESS group but did not reach statistical significance.

So far, all comparative studies have been limited by small numbers, their nonrandomized design, their retrospective nature, and the lack of standardization in the assessment of postoperative outcomes. Overall, these series have shown a noninferiority of LESS over conventional laparoscopy in terms of perioperative outcomes, with an encouraging trend toward less postoperative pain and better cosmesis.

FUTURE OF UROLOGIC LESS
=======================

LESS as a new surgical technique requires clinical validation. Not only feasibility, longer clinical follow-up, and safety results are sought after, but advocates of LESS should also assess cosmetic outcome by using a standardized and validated patient and surgeon\'s scar assessment tool, such as the Patient and Observer Scar Assessment Scale \[[@B51]\].

Historically, poor instrument ergonomics, crossing or collision of instruments, lack of triangulation, and depth perception have created limitations for universal acceptance of conventional laparoscopic surgery and similarly for acceptance of LESS. Undeniably, the use of specific instrumentation available for LESS and a solid laparoscopic surgical background are critical for successful LESS. Even with the robotic-assisted LESS system ([Fig. 1](#F1){ref-type="fig"}), the lack of instruments, lack of full range of motion, and bulky platforms pose challenges for the robotic-assisted LESS \[[@B52]\]. Ongoing new developments in this area (VeSPA-robot instruments) may surpass our expectations \[[@B53]\].

Whether patients would prefer LESS to laparoscopy remains to be determined. Bucher at al. \[[@B54]\] sent a questionnaire describing laparoscopy, LESS, and NOTES to medical and paramedical staff, surgical patients, and the general population. Given similar operative risk, 90% of the participants preferred a scarless approach to laparoscopy, and this preference was significantly higher among the younger participants.

Although \"cure\" and safety remain the main concern, it seems that the concept and perception of scarless surgery is universally favorable due to the promise of improved cosmetic outcome and quicker recovery \[[@B55]\]. As conventional laparoscopic surgery challenged open surgery, LESS examines conventional laparoscopy and tackles the need for multiple entry sites, faster patient recovery, and possible better cosmetic outcome.

CONCLUSIONS
===========

LESS has proved to be immediately applicable in the clinical field, being safe and feasible in the hands of experienced laparoscopic surgeons in well-selected patients. Despite promising early outcomes, the benefits of LESS are not obvious at present, with the only claimed advantage being cosmetic.

Prospective randomized studies are largely awaited to define the benefits of this technique for patients as well as to elucidate the cost-effectiveness of the approach. Refinement of instruments and application of robotics are likely to improve intraoperative ergonomics, allowing easier training and facilitating the current steep learning curve.

The authors have nothing to disclose.

![Stepping forward: from laparoendoscopic single-site surgery (LESS) to R-LESS (Robotic-LESS) (modified from Rane and Autorino. Curr Opin Urol 2011;21:71-7, with permission of Wolters Kluwer) \[[@B52]\]. 2D, 2 dimensions; HD, high definition.](kju-53-443-g001){#F1}

###### 

Laparoendoscopic single-site surgery toolbox: access devices, instruments, and optics
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Urologic laparoendoscopic single-site surgery procedures: what has been done so far
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Laparoendoscopic single-site surgery versus laparoscopy: reported outcomes from case-control comparative series
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LESS, laparoendoscopic single-site surgery; OT, operative time; EBL, estimated blood loss; NS, not significant; NR, not reported; IV, intravenous.

^a^:Morphine equivalents (mg), ^b^:Mean values expressed, ^c^:Additional 5-mm trocar systematically used, ^d^:Excluded from the analysis, ^e^:No. of days of IV patient-controlled anesthesia use, ^f^:Additional 5-mm trocar in one case. ^g^:mg (drug not specified).
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Laparoendoscopic single-site surgery versus laparoscopy living donor nephrectomy: comparative outcomes
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LESS, laparoendoscopic single-site surgery; BMI, body mass index; OR, operating room; EBL, estimated blood loss; VAS, visual analogue scale; N/A, not assessed.

^a^:For continuous variables, values expressed as median, ^b^:Statistically significant difference (p\<0.06).
